# Dilon Technologies acquires assets of Dune Medical including MarginProbe

Dilon Technologies Inc. acquired substantially all assets of Dune Medical, including the MarginProbe device for breast cancer surgery. The deal was announced on April 2, 2020.

- Type: Acquisition
- Announced: 2020-04-02
- Where: United States
- Status: completed
- Products: MarginProbe breast cancer margin assessment device, Navigator Gamma Probes
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Dilon Technologies](https://endata.com/companies/46313.md) (acquirer)
- [Dune Medical](https://endata.com/companies/46314.md) (target)

## Sources

- [dilon.com](https://dilon.com/2020/04/03/dilon-technologies-inc-acquires-the-dunemedicals-marginprobe/), 2020-04-03: "Dilon Technologies Inc., a world class global leader in breast cancer treatment and diagnosis and owner of the Navigator Gamma Probes has acquired substantially all the assets of Dune Medical, including Marginprobe's 'MarginProbe'."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.